Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 188

The DOI matches its Crossref record.

Effect of Somatostatin in Patients with Acromegaly: Suppression of Growth Hormone, Prolactin, Insulin and Glucose Levels

Yen, Samuel S. C., Siler, Teresa M., De Vane, Gary W.·1974·New England Journal of Medicine

Abstract

Abstract In five patients with acromegaly, the chronic hypersecretion of growth hormone was effectively inhibited by the administration of synthetic somatostatin (intravenous bolus of 250 μg followed by a constant infusion, 500 μg per 45 minutes). The rate of growth hormone decline during the infusion was rapid, with a mean half-time of 24 minutes. After the infusion, a return of secretion to previously elevated levels was observed. These data suggest that the inhibitory action of somatostatin on growth hormone secretion is nearly complete and that the biologic action of somatostatin is brief. In addition, somatostatin induced a concomitant fall in circulating levels of insulin, glucose and prolactin and an increase in fatty free acids. No effect on levels of thyrotropin, follicle-stimulating hormone or luteinizing hormone was observed. (N Engl J Med 290:935–938, 1974)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm197404252901704

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 188

Metadata

Authors
Yen, S. S. C., Siler, T. M., & De Vane, G. W.
Venue
New England Journal of Medicine
Published
1974-04-25
Volume
290
Issue
17
Pages
935-938
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2029494927
Cited by
188
References
0
FWCI
25.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Somatostatin in Patients with Acromegaly: Suppression of Growth Hormone, Prolactin, Insulin and Glucose Levels. https://app.cochat.ai/papers/10.1056/nejm197404252901704
The paper
Yen, S. S. C., Siler, T. M., & De Vane, G. W. (1974). Effect of Somatostatin in Patients with Acromegaly: Suppression of Growth Hormone, Prolactin, Insulin and Glucose Levels. New England Journal of Medicine. https://doi.org/10.1056/nejm197404252901704

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.